Fang Fund Partners

Fang Fund Partners, established in 2011 and based in Beijing, China, is a venture capital firm that specializes in early and growth stage investments. The firm focuses on innovative sectors including big data, artificial intelligence, smart technology, healthcare, new energy, and fintech. With a management team that possesses extensive experience in business practices and venture investment, Fang Fund Partners aims to provide value-added services to its portfolio companies. This includes support in areas such as capital, marketing strategies, and industry cooperation. The firm is committed to fostering entrepreneurship and social progress by aligning with quality resources and the ecological industry chain, while also leveraging its international perspective to enhance the strategic development of invested companies.

Dong Zheng

Partner

36 past transactions

SuperC

Venture Round in 2023
SuperC is a company based in Dongguan City, Guangdong, China, founded in 2012, that focuses on the research and production of innovative nanomaterials. The company specializes in developing Few Layer Graphenes (FLG), which are utilized in various applications including lithium-ion batteries, fireproof coatings, anticorrosive coatings, and materials that enhance electrical and thermal conductivity. SuperC is committed to advancing nanotechnology to create high-performance materials for diverse industries.

BioAntibody

Series A in 2023
Bioantibody is a biotechnology firm focused on the research and development of antigens, antibodies, and detection reagents for diagnostic and therapeutic applications. The company specializes in producing core raw materials for in vitro diagnostics and biopharmaceuticals, utilizing advanced targeted hybridoma cell fusion technology. This technology is complemented by stable cell growth factors and high-throughput screening methods, addressing a wide range of medical categories, including cardiovascular, cerebrovascular, inflammation, infectious diseases, tumors, and hormones. By offering high-quality raw materials, Bioantibody aims to enhance disease detection and improve therapeutic outcomes for its customers.

Baikang Bio

Series A in 2023
Baikang Bio is a tech biotechnology firm specializing in the research and development of antigens, antibodies, and downstream detection reagents for diagnosis and therapy. The product pipelines cover cardiovascular and cerebrovascular, inflammation, infectious diseases, tumors, hormones, and other categories, from raw materials to finished goods. They are dedicated to innovation and providing their customers with solutions. They could contribute to human ecology and health.

Boaoxin

Series B in 2022
Biosion is a biotech company focused on the development of biologics to treat resistant, relapsed, residual immune, and oncologic diseases.

Easy Chat Technology

Series B in 2022
YiLiao Technology has focused on the online customer-acquiring AI intelligent customer service robot track, serving the "conversation-lead" conversion scenario in marketing.

Aucta Pharmaceuticals

Series A in 2021
Aucta Pharmaceuticals is a pharmaceutical company that utilizes the 505(b)(2) regulatory pathway to enhance existing molecules into improved therapeutic products. The company focuses on developing innovative dosage forms, dosing regimens, and new indications, with a therapeutic emphasis on central nervous system disorders, ophthalmics, and inhalation therapy. Aucta commercializes both branded specialty products and technology platform-based niche generics, aiming to improve treatment options for patients. Their approach is centered on patient needs, ensuring that enhanced versions of established medications are brought to market regularly. Through its advanced drug platform, Aucta also emphasizes the development of poorly water-soluble compounds with controlled release, facilitating better patient compliance and treatment outcomes.

Denovo Biopharma

Series D in 2020
Denovo Biopharma, based in Hangzhou, China, specializes in biopharmaceutical innovation. The company offers a pioneering biomarker solution to tailor drug development. Its core technology, the first of its kind, enables retrospective de novo genomic biomarker discovery using archived clinical samples. This approach is particularly beneficial for late-stage drugs with unsatisfactory efficacy, allowing biotech and pharmaceutical companies to identify biomarkers linked to patient responsiveness. Consequently, they can design new clinical trials targeting specific patient populations, aiming to enhance drug efficacy and reduce adverse effects. The platform's broad applicability spans various therapeutic areas, including oncology, metabolic disorders, cardiology, immunology, and neurology.

3D Medicines

Series D in 2020
3D Medicines is a biopharmaceutical company focused on the research, development, and commercialization of personalized treatments for cancer. By utilizing individuals' genetic information, the company aims to enhance the prevention, diagnosis, and management of cancer as a chronic disease. 3D Medicines specializes in creating differentiated immuno-oncology drugs designed to improve patient outcomes, extending both survival time and quality of life for those affected by cancer. The company generates its revenue exclusively from the Chinese market.

G-Wearables

Private Equity Round in 2019
G-Wearables is a tech start-up focused on fashionable and versatile electronic wearables.

Yimi Station

Series A in 2018
Yimi Station is a Shenzhen-based company that offers a food ordering and delivery service through its innovative application. The platform allows users to place online orders and have their meals delivered to nearby smart food boxes, which feature automatic temperature control and can be accessed via QR codes. In addition to food delivery, Yimi Station provides catering, food retail, storage, and logistics services, emphasizing the use of modern technology within the food industry. With nearly 20 years of industry experience, the company aims to enhance the dining experience through its gourmet intelligent kitchen cabinets and a food research and development platform. Yimi Station has gained recognition for its unique approach to personalized dining, particularly in campus settings, where it seeks to offer nutritious and convenient meal options for students and workers alike.

TCR Cure

Series A in 2018
Chongqing TCRCure Biotechnology Co., Ltd. is a Beijing-based company that specializes in the research, development, and industrialization of tumor immune cell therapies. The firm offers a range of products and services, including universal T cell receptor chimeric T cell therapy, individualized TCR tumor immune cell customization therapy, and CAR-T therapy. Additionally, TCRCure is involved in clinical immune monitoring and immunological efficacy assessment, as well as providing virus and carrier production for external technical services. The company emphasizes a streamlined approach to biotechnology development, focusing on high throughput antigen-specific TCR cloning, industry-scale virus production, T cell genetic engineering, and immune cell manufacturing.

Qingmu Apartment

Venture Round in 2018
Qingmu Apartment is a apartment brand operator.

Ulu

Seed Round in 2018
Ulu, established in 2014 and headquartered in Amsterdam, Netherlands, specializes in mobility-related applications and telematics solutions. The company offers a mobile app that facilitates customer interaction and navigation services for users, along with telematics devices that provide real-time vehicle data to optimize fleet management for businesses. Ulu serves a diverse range of clients, including mobility service providers, leasing companies, and dealerships, across Europe and China.

Avular

Venture Round in 2018
Avular, based in Eindhoven's innovative Strijp-T district, specializes in designing, engineering, and manufacturing professional Unmanned Aerial Vehicle (UAV) systems. Their platform integrates hardware modules, software tools, and documentation, empowering users to gather valuable data from aerial operations. The company's multi-disciplinary team, working in an open and collaborative environment, consistently pushes technological boundaries to deliver innovative drone solutions.

YUNSPACE

Series B in 2018
YunSpace operates a short-term commercial space rental platform based in Shanghai, China. Founded in 2012, the company connects organizations seeking venues for events with a diverse range of commercial real estate options. Its offerings include spaces such as exhibition halls, art galleries, cultural blocks, commercial plazas, stadiums, and cruise terminals. YunSpace provides comprehensive solutions that encompass not only the management and transaction of these spaces but also the associated cultural and creative intellectual property. By catering to various client needs, YunSpace enables users to find suitable locations for hosting activities and events.

ZooZ

Series C in 2016
Zooz is a technology company founded in 2010 that specializes in a payments platform aimed at enhancing merchants' payment performance. The platform offers a comprehensive payment application that integrates various acquirers, e-wallets, alternative payment methods, and fraud management services. By streamlining the transaction process, Zooz enables businesses to optimize their payment operations within a complex ecosystem. In July 2018, Zooz was acquired by PayU, further expanding its reach and capabilities in the payments industry.

ShareBang

Seed Round in 2016
ShareBang is an intelligent social marketing system that operates an online smart marketing platform designed to assist clients in developing marketing networks. By facilitating easier access to customers, ShareBang enables businesses to create more effective marketing campaigns. The platform's focus on leveraging social marketing strategies allows users to enhance their outreach and engagement, ultimately improving their marketing performance.

Yunzhou Intelligence Technology

Series B in 2016
Zhuhai Yunzhou Intelligence Technology Ltd. specializes in the manufacture and marketing of unmanned surface vehicles (USVs) designed for the water monitoring sector. Founded in 2010 and based in Zhuhai, China, the company offers a range of robotic water samplers and inspectors in various sizes, along with essential accessories such as handheld terminals, base stations, and outboard motors. Its products facilitate diverse applications, including routine and emergency water sampling, spatial distribution analysis of water quality factors, lake floor topographic surveying, pollution source tracking, and studies of lake and coastal waters. Yunzhou's technology also aids in predicting algae blooms, contributing to environmental monitoring efforts. The company distributes its products through a network of dealers worldwide.

Oase

Series A in 2015
Oase is a app, you connect from your device to our server and have access to a PC that runs everything in the best quality and performance.

baolaitong.com

Angel Round in 2015
Beijing Baolaitong Technology Co., Ltd., established in 2010 and headquartered in Beijing, China, specializes in providing internet technology services tailored to the medical industry. The company focuses on developing solutions for the pharmaceutical sector, including a distribution management system for off-hospital settings and an integrated patient assistance system. These offerings enable hospitals to efficiently manage various aspects of medical treatment, including medication distribution and patient payments, thereby enhancing operational effectiveness in healthcare delivery.

Science For Life

Series A in 2015
Science For Life offers telemedicine solutions and services. They work on product development, program design, project construction, technical support, and service operations in the field of telemedicine. Their solutions include two way referral, post-hospital follow-up, remote monitoring, mobile medical, and teleconsultation.

Oase

Seed Round in 2015
Oase is a app, you connect from your device to our server and have access to a PC that runs everything in the best quality and performance.

Sunointech

Series A in 2015
Sunointech, based in China, specializes in mobile interactive marketing services. The company focuses on enhancing user engagement through innovative marketing strategies and solutions tailored for mobile platforms. By leveraging technology to create interactive experiences, Sunointech aims to help businesses effectively reach and connect with their target audiences in an increasingly digital landscape.

72 Bian

Angel Round in 2014
72 Bian is an e-commerce platform for electronics and computer hardware products.

123haitao.com

Angel Round in 2014
123haitao.com is a content-sharing website for shopping experiences and information based on social sharing. is positioned in the sharing and exchange of overseas online shopping experiences, educating users on how to shop in overseas e-commerce, how to choose a shipping firm, and selecting preferable information from overseas e-commerce to make personal remarks on purchases.

Sunointech

Angel Round in 2014
Sunointech, based in China, specializes in mobile interactive marketing services. The company focuses on enhancing user engagement through innovative marketing strategies and solutions tailored for mobile platforms. By leveraging technology to create interactive experiences, Sunointech aims to help businesses effectively reach and connect with their target audiences in an increasingly digital landscape.

BeyondSpring

Series A in 2014
BeyondSpring is a clinical-stage biopharmaceutical company based in New York that specializes in developing cancer therapies, particularly in the field of immuno-oncology. Founded in 2010, the company’s primary focus is on its lead asset, Plinabulin, which is undergoing late-stage clinical trials as a treatment for advanced non-small cell lung cancer (NSCLC), specifically aimed at preventing chemotherapy-induced neutropenia. BeyondSpring is also exploring the use of Plinabulin in combination with various immuno-oncology agents, such as nivolumab and ipilimumab, to treat different cancer types. Furthermore, the company is advancing a drug development platform that leverages the ubiquitin-mediated protein degradation pathway and is working on three small molecule immune agents in preclinical stages. The company collaborates with notable institutions, including the Fred Hutchinson Cancer Research Center and the University of Washington, to enhance its research and development efforts.

Shanghai Baison Software

Series C in 2014
Shanghai Baison Software Co., Ltd. is a Shanghai-based company established in 2000, specializing in the development of enterprise resource planning software tailored for the apparel, accessories, and home textile industries. The company offers comprehensive management systems for retail businesses, encompassing various sectors such as sports, furniture, cosmetics, beauty, jewelry, and food. Baison Software provides a range of services, including retail distribution, supply chain management, e-commerce solutions, mobile applications, and big data analytics. With a network of over 100 service agencies across China, the company supports the daily operations of more than 30 million physical stores and over 20,000 online shops. Baison Software is dedicated to facilitating the transformation and innovation of Chinese retailers, aiming to enhance brand value through advanced retail solutions and operational services.

Zannan

Series B in 2014
Zannan Technology is a fast-growing high-tech company focused on scientific and technological innovation, and it is dedicated to the research and development, production, and sale of high-performance catalysts and new polymer materials.

Yunzhou Intelligence Technology

Series A in 2014
Zhuhai Yunzhou Intelligence Technology Ltd. specializes in the manufacture and marketing of unmanned surface vehicles (USVs) designed for the water monitoring sector. Founded in 2010 and based in Zhuhai, China, the company offers a range of robotic water samplers and inspectors in various sizes, along with essential accessories such as handheld terminals, base stations, and outboard motors. Its products facilitate diverse applications, including routine and emergency water sampling, spatial distribution analysis of water quality factors, lake floor topographic surveying, pollution source tracking, and studies of lake and coastal waters. Yunzhou's technology also aids in predicting algae blooms, contributing to environmental monitoring efforts. The company distributes its products through a network of dealers worldwide.

HYGIA

Private Equity Round in 2013
HYGIA is a comprehensive enterprise integrating the design, manufacture, sales, installation, maintenance, and technical services of environmental protection sewage, sludge, and waste liquid treatment equipment.

Long Institute

Series A in 2013
Long Institute is a data research institute that focuses on big data services, providing data management, mining and services.

Tvmining

Series B in 2012
Tvmining is a Beijing-based company that specializes in developing media cloud computing services, online applications, and system technology solutions for the domestic broadcasting, television, and new media industry. Their focus is on providing innovative solutions to enhance the media landscape in China through cutting-edge technology and software development.

Miliyo

Private Equity Round in 2010
Miliyo is a dating platform. Miliyo is available for ios and android systems. They implement a video authentication mechanism to prevent fake photos. Through their mechanism that offers manual on duty patrols, user reports, and illegal keyword alerts, they eliminate illegal information and lock relevant users.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.